Sei Investments CO Biotechnology

Sei Investments CO

$75 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
GLUE Monte Rosa Therapeutics, Inc.	$267M	$80,000 0.0% of portfolio	17,341	Q1 2025 New
ATNM Actinium Pharmaceuticals, Inc.	$46.8M	$79,000 0.0% of portfolio	49,214	Q4 2024 New
TNGX Tango Therapeutics, Inc.	$594M	$78,000 0.0% of portfolio	57,086	Q1 2025 New
ALLO Allogene Therapeutics, Inc.	$217M	$70,000 0.0% of portfolio	48,320	Q4 2024 New
RLAY Relay Therapeutics, Inc.	$442M	$67,000 0.0% of portfolio	25,630	Q1 2025 New
NKTR Nektar Therapeutics	$4.61B	$64,000 0.0% of portfolio	94,152	Q4 2024 Added 50.65%
PYXS Pyxis Oncology, Inc.	$43.9M	$59,000 0.0% of portfolio	61,140	Q4 2024 New
CRBU Caribou Biosciences, Inc.	$144M	$58,000 0.0% of portfolio	64,364	Q4 2024 New
FATE Fate Therapeutics Inc	$121M	$53,000 0.0% of portfolio	67,843	Q1 2025 New
RAPT Rapt Therapeutics, Inc.	$375M	$49,000 0.0% of portfolio	40,218	Q4 2024 New
ACIU Ac Immune Sa	$203M	$46,000 0.0% of portfolio	24,897	Q1 2025 New
MGNX Macrogenics Inc	$109M	$43,000 0.0% of portfolio	34,016	Q1 2025 New
OCGN Ocugen, Inc.	$243M	$42,000 0.0% of portfolio	59,981	Q3 2024 New
NKTX Nkarta, Inc.	$104M	$41,000 0.0% of portfolio	22,788	Q4 2024 New
VTYX Ventyx Biosciences, Inc.	$181M	$41,000 0.0% of portfolio	35,764	Q4 2024 Reduced 0.1%
QSI Quantum Si Inc	$236M	$39,000 0.0% of portfolio	33,103	Q2 2024 Reduced 4.6%
FGEN Fibrogen Inc	$678M	$39,000 0.0% of portfolio	126,754	Q4 2024 Reduced 43.58%
TNYA Tenaya Therapeutics, Inc.	$36M	$39,000 0.0% of portfolio	69,702	Q4 2024 New
ALXO Alx Oncology Holdings Inc	$22M	$37,000 0.0% of portfolio	60,795	Q4 2024 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$188M	$36,000 0.0% of portfolio	41,042	Q1 2025 Reduced 0.05%
STRO Sutro Biopharma, Inc.	$48M	$36,000 0.0% of portfolio	56,347	Q4 2024 New
BDTX Black Diamond Therapeutics, Inc.	$109M	$35,000 0.0% of portfolio	22,802	Q4 2024 New
IBRX Immunity Bio, Inc.	$1.2B	$35,000 0.0% of portfolio	11,809	Q1 2025 New
ADCT Adc Therapeutics Sa	$251M	$32,000 0.0% of portfolio	22,989	Q4 2024 New
CDXS Codexis, Inc.	$212M	$31,000 0.0% of portfolio	11,708	Q1 2025 Reduced 6.77%
LYEL Lyell Immunopharma, Inc.	$2.58B	$30,000 0.0% of portfolio	55,900	Q3 2024 New
SANA Sana Biotechnology, Inc.	$976M	$29,000 0.0% of portfolio	17,668	Q3 2024 New
HRTX Heron Therapeutics, Inc.	$226M	$27,000 0.0% of portfolio	12,685	Q4 2024 Reduced 14.31%
IPSC Century Therapeutics, Inc.	$38.9M	$25,000 0.0% of portfolio	52,748	Q4 2024 New
MRSN Mersana Therapeutics, Inc.	$31.1M	$23,000 0.0% of portfolio	69,527	Q4 2024 New
ABOS Acumen Pharmaceuticals, Inc.	$65.2M	$23,000 0.0% of portfolio	21,782	Q3 2024 New
ERAS Erasca, Inc.	$209M	$22,000 0.0% of portfolio	16,682	Q2 2024 New
LRMR Larimar Therapeutics, Inc.	$163M	$22,000 0.0% of portfolio	10,573	Q3 2024 New
ALEC Alector, Inc.	$148M	$20,000 0.0% of portfolio	16,884	Q1 2025 New
HOWL Werewolf Therapeutics, Inc.	$40.5M	$20,000 0.0% of portfolio	21,322	Q3 2024 New
CCCC C4 Therapeutics, Inc.	$112M	$19,000 0.0% of portfolio	12,429	Q1 2025 Added 0.24%
CABA Cabaletta Bio, Inc.	$48.5M	$16,000 0.0% of portfolio	12,181	Q1 2025 Reduced 0.2%
ADAP Adaptimmune Therapeutics PLC	$53.9M	$10,000 0.0% of portfolio	54,824	Q1 2025 New
RLMD Relmada Therapeutics, Inc.	$19.2M	$9,000 0.0% of portfolio	36,230	Q4 2024 Reduced 0.25%
ALLK Allakos Inc.	$28M	$4,000 0.0% of portfolio	21,553	Q1 2025 New
LYRA Lyra Therapeutics, Inc.	$255M	$3,000 0.0% of portfolio	30,067	Q1 2025 Reduced 64.24%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	95,034	Q1 2025 Reduced 12.23%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.